ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society. It covers original research on the molecular underpinnings of nerve function in organisms and animal models. The journal was established in September, 2009, ahead of the publication of the first issue in January 2010. The journal is one of the first journals of the American Chemical Society to be available in online-only format. The founding editor in chief is Craig W. Lindsley (Vanderbilt University). Notable authors include Joanna S. Fowler, Nora Volkow, and P. Jeffrey Conn. ACS Chemical Neuroscience publishes research letters, articles, and reviews that all are peer-reviewed. In addition, specially commissioned articles that describe journal content and advances in neuroscience are solicited from leaders in the field. Because of the online-only format, researchers can use functionalities available only on the web. The journal presents research dealing with diverse topics covering all areas of neuroscience such as neural development, plasticity, and degeneration; molecular and chemical analysis of neurotransmitters and receptors; design and development of pharmaceuticals
A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic ...
Aug 16, 2017
2
1861
Case reports of relatively young COVID-19 patients who developed Parkinson's disease within weeks of contracting the virus have led scientists to wonder if there could be a link between the two conditions. Now, researchers ...
Dec 14, 2021
0
1992
A team of University of California, Irvine researchers has discovered a possible reason why L-dopa, the front-line drug for treating Parkinson's disease, loses efficacy and causes dyskinesia—involuntary, erratic muscle ...
Jan 20, 2022
0
254
When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of ...
May 7, 2020
0
233
Copper exposure in the environment and the protein alpha-synuclein in the human brain could play an important role in the pathogenesis of Parkinson's disease. A team from Empa and the University of Limerick was able to show ...
Jul 7, 2022
0
99
Doctors have reported that partial or total loss of the sense of smell is often an early symptom of infection with SARS-CoV-2, the virus that causes COVID-19. Now, researchers reporting in ACS Chemical Neuroscience have shown ...
May 11, 2020
0
46
A team of researchers from the University of Saskatchewan has developed two caffeine-based chemical compounds that show promise in preventing the ravages of Parkinson's disease.
Sep 30, 2016
0
166
Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988. Thirty years later, scientists still don't know exactly how the medication exerts its mood-lifting ...
Jul 10, 2019
0
3
New evidence puts into doubt the long-standing belief that a deficiency in serotonin—a chemical messenger in the brain—plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that ...
Aug 27, 2014
0
0
Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage to the brain from Alzheimer's disease occurs years before patients ...
Nov 12, 2019
0
183
